[TREATMENT WITH ENZYMATIC INACTIVATORS (TRASYLOL) IN THE HEMORRHAGIC FIBRINOLYTIC SYNDROME DURING EXTRACORPOREAL CIRCULATION].
D001024:Aortic Valve Stenosis; D007611:Aprotinin; D006348:Cardiac Surgical Procedures; D002648:Child; D004791:Enzyme Inhibitors; D005112:Extracorporeal Circulation; D005342:Fibrinolysis; D006343:Heart Septal Defects; D006345:Heart Septal Defects, Ventricular; D006354:Heart, Artificial; D006470:Hemorrhage; D007610:Kallikreins; D008946:Mitral Valve Stenosis; D013903:Thoracic Surgery; D013916:Thrombelastography; D014357:Trypsin
D004791:Enzyme Inhibitors; D007611:Aprotinin; D007610:Kallikreins; D014357:Trypsin
AORTIC VALVE STENOSIS; CHILD; ENZYME INHIBITORS; FIBRINOLYSIS; HEART SEPTAL DEFECTS, VENTRICULAR; HEART SURGERY; HEART, MECHANICAL; HEMORRHAGE; KALLIKREIN; MITRAL VALVE STENOSIS; THROMBOELASTOGRAPHY; TRYPSIN
TRATTAMENTO CON INATTIVATORE ENZIMATICO (TRASYLOL) DELLA SINDROME FIBRINOLITICA EMORRAGICA IN CORSO DI CIRCOLAZIONE EXTRACORPOREA.